Do remotely think that a new unfounded therapy with manufactured cells being IPSC's are going to be passed anytime soon, over what the FDA can't already get their head around that is being used throughout the world?
1. They’re not “unfounded.”
2. Your sentence makes no sense (big night on the bottle again?).
3. There are good reasons why tissue-derived MSCs are running into issues with the FDA. This is all out in the public domain.
4. Question for you: How long transpired between Cynata submitting an application to run a P2 trial in GvHD and it being accepted by the FDA?
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
3.13%
!
15.5¢

Ann: Investor Presentation, page-191
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 9763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 0.155 |
5 | 106673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
1 | 26000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 9763 | 1 |
0.165 | 38474 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 62619 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman & CEO
Hank Holland
Chairman & CEO
Previous Video
Next Video
SPONSORED BY The Market Online